David Bredt

Chief Scientific Officer

David Bredt (Chief Scientific Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $231K of RAPP (7,704 sh × $29.95, as filed), executed Dec 15 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.1M

shares × price, as filed

Last traded

Feb 17

Filed Feb 19

Median ADV $17.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

RAPP

Rapport Therapeutics, Inc. RAPP · 0 buys · 9 sells 9 filings

Recent filings

RAPPSALE Rapport Therapeutics, Inc. View filing → $156K
5,400 sh × $28.95
Exec Feb 17
Filed Feb 19 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $223K
8,300 sh × $26.83
Exec Jan 15
Filed Jan 16 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $197K
6,567 sh × $30.05
Exec Dec 31 2025
Filed Jan 5 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $231K
7,704 sh × $29.95
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $136K
5,344 sh × $25.39
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $191K
7,418 sh × $25.73
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $122K
5,098 sh × $23.88
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $124K
8,300 sh × $14.98
Exec Aug 15 2025
Filed Aug 18 2025 · 5:30 PM ET More filings →